Article: Grass pollen allergy vaccine performance persists

Article from:
Inpharma Weekly
Article date:
November 1, 2008
Author:
Copyright

For the first time, the positive clinical effects of ALK Abello's grass pollen allergy vaccine [Grazax] have been shown to persist after the cessation of the therapy.

In the GT-08 study, patients adhered to the recommended 3-year treatment with the tablet-based vaccine up until the autumn of 2007, with the follow-up year being the 2008 pollen season; this was the first season in which patients did not receive active treatment with the vaccine.

The results from the vaccine recipients were compared with those from a control group of patients with unrestricted access to symptom-relieving ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: A sublingual grass pollen allergy vaccine ...
Inpharma Weekly;  September 6, 2008 ;     345 words ...A sublingual grass pollen allergy vaccine tablet [Oralair Grasses] has shown positive results ... sublingual immunotherapy was administered to 86 adult patients with grass pollen rhinoconjunctivitis. The outcomes of this trial were: an onset ...

Article: Positive two-year data for ALK-Abello's Grazax.(preventing ...
Pharma Marketletter;  March 5, 2007 ;     660 words ... ... line results from the second treatment year in a long-term study of Grazax, its tablet-based vaccine against grass pollen allergy. According to the firm, the agent showed increased clinical effect and immunological changes in the second treatment ...

Article: ALK-Abello's Grazax approved in Europe.(approval for Grazax the ...
Pharma Marketletter;  October 2, 2006 ;     623 words ...Authorities in 27 European countries have now approved ALK-Abello's tablet-based vaccine against grass pollen allergy, Grazax - the first allergy tablet to address the underlying cause of the disease. The Denmark-based company ...

Article: SUBLINGUAL IMMUNOTHERAPY HELPS GRASS-POLLEN ...
HealthInform: Essential Information on Alternative Health Care;  February 1, 1999 ;     700+ words ... ... mean age, 27 years) who suffer from grass-pollen allergies (as confirmed through testing ... immunotherapy, using a standardized grass-pollen extract, in diminishing the patients ... The SLIT regimen with standardised grass-pollen extract was well tolerated and reduced ...

Article: STUDY REINFORCES CLINICAL EFFICACY OF ALK-ABELLO'S TABLET AGAINST ...
AsiaPulse News;  January 12, 2005 ;     700+ words ... ... includes more than 600 patients allergic to grass pollen," he says. The World Health Organisation ... which approximately 50% are allergic to grass pollen, and the prevalence continues to increase ... to-severe rhinoconjunctivitis and grass pollen induced mild-to-moderate asthma ...

Article: New Study Reinforces Safety and Clinical Efficacy of ALK-Abello's ...
PR Newswire;  January 6, 2005 ;     700+ words ... ... includes more than 600 patients allergic to grass pollen," he says. The World Health Organisation ... which approximately 50% are allergic to grass pollen, and the prevalence continues to increase ... to-severe rhinoconjunctivitis and grass pollen induced mild-to-moderate asthma ...

Article: Up-and-down allergy season eases.(Health)(Grass ...
The Register-Guard (Eugene, OR);  July 11, 2005 ;     700+ words ... ... private allergy clinic. "Every time the grass (pollen count) would start to climb, we would ... said. "It certainly wasn't our worst grass pollen season." The dreaded grass-pollen allergy season typically lasts about six weeks ...

Article: NEW VACCINE RELIEVES BIRCH POLLEN ALLERGY
United Press International;  August 16, 2004 ;     700+ words ... ... relieves birch pollen allergy NEW YORK, Aug ... allergies, such as grass pollen, house dust ... is allergic to grass pollen, he or she is ... targeted birch pollen allergy, one of the ... something like grass pollen, which has four ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives